Libra Infusions Limited Share Price

Equities

LIBRAINFU

BD0471LBINF8

Pharmaceuticals

End-of-day quote Dhaka S.E. 03:30:00 29/04/2024 am IST 5-day change 1st Jan Change
766.5 BDT -2.37% Intraday chart for Libra Infusions Limited +6.41% -16.75%

Financials

Sales 2016 238M 2.18M 182M Sales 2017 244M 2.24M 187M Capitalization 653M 5.99M 500M
Net income 2016 5M 45.86K 3.83M Net income 2017 6M 55.04K 4.59M EV / Sales 2016 6.88 x
Net Debt 2016 880M 8.07M 673M Net Debt 2017 894M 8.2M 685M EV / Sales 2017 6.34 x
P/E ratio 2016
131 x
P/E ratio 2017
107 x
Employees 699
Yield 2016
0.41%
Yield 2017
0.57%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.37%
1 week+6.41%
Current month+0.10%
1 month+1.81%
3 months-15.51%
6 months-29.60%
Current year-16.75%
More quotes
1 week
682.30
Extreme 682.3
805.20
1 month
682.30
Extreme 682.3
805.20
Current year
682.30
Extreme 682.3
950.00
1 year
445.73
Extreme 445.7333
1 146.67
3 years
350.00
Extreme 350
1 146.67
5 years
292.60
Extreme 292.6
1 146.67
10 years
153.61
Extreme 153.6111
1 146.67
More quotes
Managers TitleAgeSince
Founder - 02/76/02
Director of Finance/CFO - -
Chairman - -
Members of the board TitleAgeSince
Founder - 02/76/02
Chairman - -
Director/Board Member - -
More insiders
Date Price Change Volume
29/24/29 766.5 -2.37% 25,098
28/24/28 785.1 +4.12% 42,915
25/24/25 754 +7.19% 26,342
24/24/24 703.4 +0.73% 14,986
23/24/23 698.3 -3.05% 13,650

End-of-day quote Dhaka S.E., April 29, 2024

More quotes
Libra Infusions Ltd is a Bangladesh-based company engaged in manufacturing of Intravenous (I.V.) fluid. The Company's products include LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400 AND LIBRET. Its products are medical necessities used in medical situations involving diarrheal disease, surgical operation, loss of blood, weakness and hospitalization in general. LIBOTT is used for rehydration at the time of water deficit, general weakness and post-surgical intervention. LIBOTT-10 is used for the treatment of jaundice, general weakness, eclampsia and pre-eclampsia. LIBOTT-25 is used in the emergency treatment of severe hypoglycemia. LIBOTT-S is used for rehydration during general weakness, water deficiency along with sodium, diuresis, intoxication and post-surgical intervention. LIBOTT-S JR fulfills water deficit along with low deficiency of sodium chloride and supplies energy for growing children.
More about the company
  1. Stock Market
  2. Equities
  3. LIBRAINFU Stock